Abstract. The phylogenetic position of Triatoma sherlocki within triatomines group was inferred by analyzing mtDNA fragments of Cyt B and 16S ribosomal RNA by using maximum parsimony and Bayesian analysis. Despite being differentiated from members of the T. brasiliensis complex on morphologic grounds, molecular phylogenetic analysis suggests T. sherlocki is a member of this complex; moreover, it was placed as a sister species of T. melanica . These suggestions were supported by robust credibility rates. Hence, we show evidence for the paraphyletic group of the " Triatoma brasiliensis complex," which should be composed of T. brasiliensis brasiliensis , T. brasiliensis macromelasoma , T. juazeirensis , T. melanica , and T. sherlocki .
The phylogenetic relationships among species of
Triatoma matogrossensis subcomplex (
T. baratai,
T. guazu,
T. matogrossensis,
T. sordida,
T. vandae, and
T. williami) was addressed by using fragments of cytochrome oxidase I (COI), 16S rDNA (16S), and cytochrome
b (Cytb) through Bayesian and parsimony analyses. We did not recover a monophyletic
T. matogrossensis subcomplex, and their members were found clustered in three strongly supported clades, as follows: i)
T. jurbergi +
T. matogrossensis +
T. vandae +
T. garciabesi +
T. sordida; ii) with
T. guasayana as the sister group of clade (i); and iii)
T. williami +
T. guazu, however not closely related to the clade formed by the previously mentioned species. The other two endemic species from Central-Western Brazil,
T. baratai and
T. costalimai, were not recovered with strong clade support as related to other members of this subcomplex. Results call for a further revision in the classification of the subcomplexes within the genus
Triatoma.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.